Fibromyalgia Trial, Recruiting NCT05851326 Sponsor: Sobet AG Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT05851326
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 to 99 years old at the time of screening
  • People who understand what the study involves, agree to its procedures, and sign a written consent form before any study activities begin
  • People who have been living with chronic pain from myofascial pain syndrome (a condition involving muscle and soft tissue pain) for at least 3 months, where the pain is specifically low back pain, tension headaches, or neck pain, and where myofascial pain syndrome is the main cause of that pain
  • People whose pain treatment has stayed the same for at least 1 week during the screening period
  • People whose pain scores average 4 or more (on a 0–10 scale) on at least 4 out of 7 days during the screening period
  • People who have shown they can consistently complete the required daily pain reporting

Who may not be able to join:

  • People who have active implanted medical devices (such as a pacemaker)
  • People who have an allergy to the emergency or backup medication used in the study
  • People who are pregnant
  • People who have mental or physical conditions that could make using the study device unsafe
  • People who have epilepsy or cerebral spasms
  • People who have a psychiatric illness or a pain condition classified as somatoform (where psychological factors are a primary driver)
  • People who are taking high-dose opioid pain medication (equivalent to more than 120mg of oral morphine per day)
  • People who are taking centrally acting muscle relaxants, such as Sirdalud (tizanidine) or benzodiazepines
  • People who have a medical reason they cannot take anti-inflammatory medications (NSAIDs)
  • People who have artificial joints made from methylmethacrylate or polyethylene at the area where the study device would be used
  • People who have ferromagnetic metal implants (such as certain aneurysm clips or dental implants) at the area where the study device would be used

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rudolf Likar, Prof. Dr., Klinikum Klagenfurt am Wörthersee

Phone: +49 1511 0177825

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sobet AG
Registry
ClinicalTrials.gov
Start date
25 May 2023
Est. completion
1 March 2027

Where this trial is recruiting

🇦🇹 Austria 🇨🇭 Switzerland

Primary endpoints

Average Numeric Rating Scale (NRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov